Top Market Shifts Transforming the Immunoglobulins Market Landscape: Key Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Immunoglobulins Market Through 2025?
The market size of immunoglobulins has seen a strong increase in the recent past. The projected growth sees it scaling up from $18.85 billion in 2024 to $20.32 billion by 2025, with a compound annual growth rate (CAGR) of 7.8%. The historical period growth is attributable to factors such as a rise in immunodeficiency disorders, an increase in the elderly population, higher utilization of immunoglobulins in hospitals, supportive government reimbursement policies, as well as an increased occurrence of chronic and autoimmune diseases.

What's the Projected Size of the Global Immunoglobulins Market by 2029?
The immunoglobulins market is set for a robust growth spurt in the coming years, with an expected size of "$30.89 billion by 2029," demonstrating a compound annual growth rate (CAGR) of 11.0%. This surge during the forecast period is largely due to increased investment into the development of cutting-edge technologies, a rising understanding of immunodeficiency treatments, a growing preference among medical professionals for these treatments, the rise of new markets, and the broadening of applications into the realms of sports and fitness. Significant trends moving into this forecast period include the creation of wearable and intelligent compression devices, bespoke compression therapy solutions, the blending of compression therapy with wound care management, a focus on patient comfort and compliance within the realm of compression therapy, and strategic collaborations between manufacturers and healthcare providers to enhance patient results.

View the full report here:
https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Top Growth Drivers in the Immunoglobulins Industry: What's Accelerating the Market?
The growth of the immunoglobulins market is influenced by the escalating elderly population. This segment of the population is significantly prone to infectious and autoimmune diseases. The functionality of the immunoglobulin test lies in its capacity to measure the body's ability to generate antibodies, which shield against bacteria, viruses, and allergies. For instance, a World Health Organization (WHO) report from October 2022 projected that one in six people worldwide would be 60 or above by 2030. Moreover, by 2050, the number of people aged 60 or above globally will reach 2.1 billion. Consequently, the escalating number of elderly individuals is anticipated to enhance the demand for the immunoglobulins market in the future.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

What Are the Key Trends Driving Immunoglobulins Market Growth?
Top-tier firms in the immunoglobulins industry are innovating and offering products like intravenous immunoglobulins with the objective of expanding their customer reach and boosting their profits. A case in point is the release of ALYGLOTM (Immune Globulin Intravenous, Human-stwk) 10% Liquid by GC Biopharma, a biotech business based in South Korea, in September 2024 for the U.S market. It is designed specifically for adults 17 years and older who suffer from primary humoral immunodeficiency (PI) and can be accessed via specialised pharmacies. With the U.S. being the largest international market for immunoglobulin with an approximate value of $11.6 billion, this launch holds immense potential. GC Biopharma's goal for ALYGLO's first-year sales is set at $50 million, with a long-term objective to raise this number to $300 million by the year 2028. An essential element of their aggressive growth map includes forming alliances with major U.S. pharmacy benefit managers and specialty pharmacies, given their pivotal role in the efficient distribution of immunoglobulin products.

What Are the Main Segments in the Immunoglobulins Market?
The immunoglobulins market covered in this report is segmented -

1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:
1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)
2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA
3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM
4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE
5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=5284&type=smp

Which Top Companies are Driving Growth in the Immunoglobulins Market?
Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Which Regions Will Dominate the Immunoglobulins Market Through 2029?
North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5284

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email:saumyas@tbrc.info
The Business Research Company -www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.